IL1B and Alzheimer disease: Circulating levels of systemic inflammatory mediators, such as interleukin (IL)-1β and tumor necrosis factor (TNFα), are chronically upregulated in AD, while an increased risk for AD is linked to systemic inflammatory conditions such as Type 2 diabetes, obesity, and rheumatoid arthritis [14,15].